Back to UBS Group AG UBS Group AG

ANIXANIX
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in ANIXA BIOSCIENCES INC

UBS Group AG holds 585,430 shares of ANIX (ANIXA BIOSCIENCES INC), worth $1.6M as of 2026-Q2. The position was increased (+6.1% shares). ANIX represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.6M

Current Shares

585,430

Total Value Change

-$28,399

Total Shares Change

+56,032

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
585,430
+6.1%
$1.6M0.0%$2.80
27
2026-Q1
Increased
551,637
+20.2%
$1.4M0.0%$2.83
30
2025-Q4
Decreased
459,073
-3.3%
$1.4M0.0%$3.12
0
2025-Q3
Decreased
474,480
-6.1%
$1.6M0.0%$3.41
0
2025-Q2
Decreased
505,290
-3.6%
$1.7M0.0%$3.22
0
2025-Q1
Decreased
524,162
-1.9%
$1.5M0.0%$2.97
0
2024-Q4
Increased
534,124
+0.9%
$1.2M0.0%$2.50
25
2024-Q3
Decreased
529,398
-0.2%
$1.7M0.0%$3.19
0

Other major holders of ANIX: VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used